OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
Optimizing the use of partners for clinical trials depends on selecting the right contractor.
Recent outsourcing trends include early development services, biosimilar production, and RNA technology.
Strategizing drug development in the preclinical phase has merit.
May 19, 2022
Demand for outsourced services of technical R&D activities is increasing.
May 16, 2022
To build trust and ensure a high-quality product, companies must be sure their contracts are firm and their lines of communication even firmer.
May 15, 2022
CDMOs offer expertise and customization options for sponsors of orphan drugs.
CDMOs need to consistently demonstrate agility as demand increases for newly developed therapeutic modalities.
Acquisitions in the CDMO space can give us insight into a company's vision for their future.
Industry experts share their top outsourcing tips from both the perspective of companies offering outsourcing
services as well as for companies looking to outsource.
The author describes how to seize market opportunities while navigating the requirements of both drug therapies and delivery devices.
May 11, 2022
Outsourcing partners are ready to fill the market need for greater cell therapies capacities.
May 01, 2022
Understanding both the challenges and solutions of aseptic manufacturing.
Applying modeling methods in preclinical studies can be a powerful tool for generating data and shortening development timelines.